A critical advance in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This essential malignant inhibitor protein is frequently inactivated in various kinds of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research